Advanced search
Publication Cover
Modern Rheumatology Volume 19, 2009 - Issue 6
Journal homepage
22
Views
6
CrossRef citations to date
0
Altmetric
Original Article

Prediction of DAS28-CRP remission in patients with rheumatoid arthritis treated with tacrolimus at 6 months by baseline variables

Toshiyuki AramakiUnit of Translational Medicine, Department of Immunology and Rheumatology, Graduate School of Biomedical Sciences, Nagasaki University, 1-7-1 Sakamoto, Nagasaki 852-8501, Japan
,
Atsushi KawakamiUnit of Translational Medicine, Department of Immunology and Rheumatology, Graduate School of Biomedical Sciences, Nagasaki University, 1-7-1 Sakamoto, Nagasaki 852-8501, Japan
,
Naoki IwamotoUnit of Translational Medicine, Department of Immunology and Rheumatology, Graduate School of Biomedical Sciences, Nagasaki University, 1-7-1 Sakamoto, Nagasaki 852-8501, Japan
,
Keita FujikawaUnit of Translational Medicine, Department of Immunology and Rheumatology, Graduate School of Biomedical Sciences, Nagasaki University, 1-7-1 Sakamoto, Nagasaki 852-8501, Japan
,
Shin-ya KawashiriUnit of Translational Medicine, Department of Immunology and Rheumatology, Graduate School of Biomedical Sciences, Nagasaki University, 1-7-1 Sakamoto, Nagasaki 852-8501, Japan
,
Mami TamaiUnit of Translational Medicine, Department of Immunology and Rheumatology, Graduate School of Biomedical Sciences, Nagasaki University, 1-7-1 Sakamoto, Nagasaki 852-8501, Japan
,
Kazuhiko ArimaUnit of Translational Medicine, Department of Immunology and Rheumatology, Graduate School of Biomedical Sciences, Nagasaki University, 1-7-1 Sakamoto, Nagasaki 852-8501, Japan
,
Makoto KamachiUnit of Translational Medicine, Department of Immunology and Rheumatology, Graduate School of Biomedical Sciences, Nagasaki University, 1-7-1 Sakamoto, Nagasaki 852-8501, Japan
,
Satoshi YamasakiUnit of Translational Medicine, Department of Immunology and Rheumatology, Graduate School of Biomedical Sciences, Nagasaki University, 1-7-1 Sakamoto, Nagasaki 852-8501, Japan
,
Hideki NakamuraUnit of Translational Medicine, Department of Immunology and Rheumatology, Graduate School of Biomedical Sciences, Nagasaki University, 1-7-1 Sakamoto, Nagasaki 852-8501, Japan
,
Munetoshi NakashimaThe Japanese Red Cross Nagasaki Atomic Bomb Hospital, Nagasaki, Japan
,
Akinari MizokamiNagasaki Citizen Hospital, Nagasaki, Japan
,
Masako FuruyamaNagasaki Kita Hospital, Nagasaki, Japan
,
Naoki MatsuokaGotokai Hospital, Nagasaki, Japan
,
Yukitaka UekiSasebo Chuo Hospital, Sasebo, Japan
,
Hiroaki IdaUnit of Translational Medicine, Department of Immunology and Rheumatology, Graduate School of Biomedical Sciences, Nagasaki University, 1-7-1 Sakamoto, Nagasaki 852-8501, Japan
,
Tomoki OriguchiNagasaki University School of Health Sciences, Nagasaki University, 1-7-1 Sakamoto, Nagasaki 852-8520, Japan
,
Kiyoshi AoyagiDepartment of Public Health, Graduate School of Biomedical Sciences, Nagasaki University, 1-7-1 Sakamoto, Nagasaki 852-8501, Japan
&
Katsumi EguchiUnit of Translational Medicine, Department of Immunology and Rheumatology, Graduate School of Biomedical Sciences, Nagasaki University, 1-7-1 Sakamoto, Nagasaki 852-8501, JapanCorrespondence[email protected]
 show all
Pages 652-656 | Received 23 Mar 2009, Accepted 14 Jul 2009, Published online: 02 Jan 2014

References

  • Kelly PA, Burckart GJ, Venkataramanan R. Tacrolimus: a new immunosuppressive agent. Am J Health Syst Pharm. 1995; 52:1569–71.
  • Fleischmann R, Iqbal I, Stern RL. Tacrolimus in rheumatoid arthritis. Expert Opin Pharmacother. 2006;7:91–8.
  • Kawai S, Yamamoto K. Safety of tacrolimus, an immunosup-pressive agent, in the treatment of rheumatoid arthritis in elderly patients. Rheumatology. 2006;45:441–4.
  • Kawai S, Tanaka K, Ohno I, Utsunomiya K, Seino Y. Safety of long-term therapy for rheumatoid arthritis: an open-label, uncontrolled study in non-elderly patients. Mod Rheumatol. 2008;18:345–53.
  • Akimoto K, Kusunoki Y, Nishio S, Takagi K, Kawai S. Safety profile of tacrolimus in patients with rheumatoid arthritis. Clin Rheumatol. 2008;27:1393–7.
  • Morita Y, Sasae Y, Sakuta T, Satoh M, Sasaki T, Kashihara N. Efficacy of low-dose tacrolimus added to methotrexate in patients with rheumatoid arthritis in Japan: a retrospective study. Mod Rheumatol. 2008;18:379–84.
  • Kremer JM, Habros JS, Kolba KS, Kaine JL, Ann Borton M, Mengle-Gaw LJ, et al. Tacrolimus in rheumatoid arthritis patients receiving concomitant methotrexate. A six-month, open-label study. Arthritis Rheum. 2003;48:2763–8.
  • Saag KG, Teng GG, Patkar NM, Anuntiyo J, Finney C, Curtis JR, et al. American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying anti-rheumatic drugs in rheumatoid arthritis. Arthritis Rheum (Arthritis Care & Research). 2008;59:762–84.
  • Inoue E, Yamanaka H, Hara M, Tomatsu T, Kamatani N. Comparison of disease activity score (DAS)28-erythrocyte sedimentation rate and DAS28-C-reactive protein threshold val-ues. Ann Rheum Dis. 2007;66: 407–9.
  • Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31:315–24.
  • Wider SL, Silman AJ, Thomson W, Lunt M, Bunn D, Symmons DP. Can clinical factors at presentation be used to predict out-come of treatment with methotrexate in patients with early inflammatory polyarthritis? Ann Rheum Dis. 2009;68:57–62.
  • van der Heijde D, Klareskog L, Landewe R, Bruyn GA, Cantagrel A, Durez P, et al. Disease remission and sustained halting of radiographic progression with combination etanercept and methotrexate in patients with rheumatoid arthritis. Arthritis Rheum. 2007;56:3928–39.
  • Tanaka Y, Takeuchi T, Inoue E, Saito K, Sekiguchi N, Sato E, et al. Retrospective clinical study on the notable efficacy and related factors of infliximab therapy in a rheumatoid arthritis management group in Japan: one-year clinical outcomes (RECONFIRM-2). Mod Rheumatol. 2008;18:146–52.
  • Suzuki K, Kameda H, Ammo K, Nagasawa H, Takei H, Sekig-uchi N, et al. Single center prospective study of tacrolimus effi-cacy and safety in treatment of rheumatoid arthritis. Rheumatol Int. 2009;29:431–6.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.